Tissue-nonspecific alkaline phosphatase is activated in enterocytes by oxidative stress via changes in glycosylation.
BACKGROUND
Intestinal inflammation produces an induction of alkaline phosphatase (AP) activity that is attributable in part to augmented expression, accompanied by a change in isoform, in epithelial cells.


METHODS
This study focuses on induction of AP in intestinal epithelial cells in vitro.


RESULTS
Treatment with the oxidants H2O2, monochloramine, or tButOOH increases AP activity in vitro in Caco-2, HT29, and IEC18 cells. We selected IEC18 cells for further testing. Basal AP activity in IEC18 cells is of the tissue-nonspecific (bone-liver-kidney) type, as indicated by Northern and Western blot analysis. Oxidative stress augments AP activity and the sensitivity of the enzyme to levamisole, homoarginine, and heat in IEC18 cells. Increased immunoreactivity to tissue-nonspecific AP antibodies suggests an isoform shift from liver to either kidney or bone type. This effect occurs without changes at the mRNA level and is sensitive to tunicamycin, an inhibitor of N-glycosylation, and neuraminidase digestion. Saponin and deoxycholate produce similar effects to oxidants. Butyrate but not proinflammatory cytokines or LPS can induce a similar effect but without toxicity. The AP increase is not prevented by modulators of the MAPK, NF-κB, calcium, and cyclic adenosine monophosphate (cAMP) pathways, and is actually enhanced by actinomycin D via higher cell stress.


CONCLUSIONS
Oxidative stress causes a distinct increase in enterocyte AP activity together with cell toxicity via changes in the glycosylation of the enzyme that correspond to a shift in isotype within the tissue-nonspecific paradigm. We speculate that this may have physiological implication for gut defense.
López-Posadas
Rocío
R
Department of Pharmacology, School of Pharmacy, University of Granada, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Campus de Cartuja, Granada, Spain.
González
Raquel
R
Ballester
Isabel
I
Martínez-Moya
Patricia
P
Romero-Calvo
Isabel
I
Suárez
María Dolores
MD
Zarzuelo
Antonio
A
Martínez-Augustin
Olga
O
Sánchez de Medina
Fermín
F
D000469:Alkaline Phosphatase / Q000235:genetics / Q000378:metabolism*; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015153:Blotting, Western; D002087:Butyrates / Q000494:pharmacology; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D020895:Enterocytes / Q000201:enzymology*; D006031:Glycosylation; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D007249:Inflammation; D007413:Intestinal Mucosa / Q000187:drug effects / Q000201:enzymology*; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism; D016877:Oxidants / Q000494:pharmacology; D018384:Oxidative Stress; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D014415:Tunicamycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002087:Butyrates; D016328:NF-kappa B; D016877:Oxidants; D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; D014415:Tunicamycin; D003609:Dactinomycin; D003513:Cycloheximide; D006861:Hydrogen Peroxide; D000469:Alkaline Phosphatase